Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,056,022)	$ (987,798)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	11,234	14,215
Equity-based compensation	8,708	25,936
Changes in assets and liabilities:
Accounts receivable	(53,120)	8,931
Contracts receivable	(18,800)
Prepaid expenses	(10,113)	59,031
Other assets	(1,038)	5,000
Accounts payable	86,598	266,805
Deferred revenue	62,708	(6,135)
Accrued and other expenses	177,642	(604,730)
Net cash used in operating activities	(792,203)	(1,218,745)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(12,281)	(2,480)
Purchase of software license	(75,000)
Capitalized patent development costs	(5,886)
Capitalized software	(250,481)
Net cash provided by (used in) investing activities	(343,648)	(2,480)
CASH FLOWS FROM FINANCING ACTIVITIES:
Restricted cash used to pay IDB interest expense	50,580	27,556
Deposit of cash to IDB restricted account	(31,247)
Proceeds from debt borrowings	1,075,000	575,000
Repayments of debt borrowings	(16,756)	(16,257)
Net cash provided by financing activities	1,077,577	586,299
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(58,274)	(634,926)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	165,139	860,211
CASH AND CASH EQUIVALENTS, END OF PERIOD	106,865	225,285
Supplemental disclosures of cash flow information:
Cash paid during the period for: Interest	$ 364,296	$ 294,332